 | |
| Clinical data | |
|---|---|
| Other names | 3-NEA; 2-(1H-Pyrrol-3-yl)ethylamine; 3-(2-Aminoethyl)pyrrole |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C6H10N2 |
| Molar mass | 110.160 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
3-Pyrrolylethylamine (3-NEA or2-(1H-pyrrol-3-yl)ethylamine) is achemical compound of thearylalkylamine family.[1] It can be thought of as theanalogue oftryptamine (2-indolylethylamine) in which thebenzene component of theindolering has been removed, leaving only apyrrole ring.[1]
The compound is also related to other arylalkylamines as well astrace amines includingphenethylamine (2-phenylethylamine),2-furylethylamine,thiopropamine (1-(2-thienyl)-2-aminopropane), andisocyclamine (cyclopentanylaminopropane), among others.[1] Many of these compounds aremonoamine releasing agents and/orreuptake inhibitors.[1]
3-NEA was first described in thescientific literature by 1965.[1]
 | Thispharmacology-related article is astub. You can help Wikipedia byexpanding it. |